The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
MEI Pharma Partners with Litecoin Creator Charlie Lee Following $100 Million Investment.
Jul 20, 2025•11 months ago
Contract Type
partnership
San DiegoBiotechnologyHealth CarePharmaceutical
Description
MEI Pharma has made a significant move by investing $100 million in Litecoin as its primary reserve asset. This partnership includes the appointment of Litecoin's creator, Charlie Lee, to its board, marking a pioneering strategy in the biopharmaceutical industry.
Company Information
Company
MEI Pharma
Location
San Diego, California, United States
About
MEI Pharma, Inc. (Nasdaq: MEIP) is a pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma’s portfolio of drug candidates includes clinical stage candidates with differentiated mechanisms of action intended to address unmet medical needs and deliver improved benefit to patients, either as standalone treatments or in combination with other therapeutic options. For more information, please visit www.meipharma.com. Follow us on Twitter @MEI_Pharma and on LinkedIn.
San DiegoBiotechnologyHealth CarePharmaceutical